Year |
Citation |
Score |
1997 |
Todorovic SM, Scroggs RS, Anderson EG. Cationic modulation of 5-HT2 and 5-HT3 receptors in rat sensory neurons: the role of K+, Ca2+ and Mg2+. Brain Research. 765: 291-300. PMID 9313902 DOI: 10.1016/S0006-8993(97)00574-X |
0.395 |
|
1994 |
Borg C, Lim CT, Yeomans DC, Dieter JP, Komiotis D, Anderson EG, Le Breton GC. Purification of rat brain, rabbit aorta, and human platelet thromboxane A2/prostaglandin H2 receptors by immunoaffinity chromatography employing anti-peptide and anti-receptor antibodies. The Journal of Biological Chemistry. 269: 6109-16. PMID 8119956 |
0.5 |
|
1994 |
Roychowdhury S, Haas H, Anderson EG. 5-HT1A and 5-HT4 receptor colocalization on hippocampal pyramidal cells. Neuropharmacology. 33: 551-7. PMID 7984294 DOI: 10.1016/0028-3908(94)90086-8 |
0.304 |
|
1992 |
Todorovic S, Anderson EG. Serotonin preferentially hyperpolarizes capsaicin-sensitive C type sensory neurons by activating 5-HT1A receptors. Brain Research. 585: 212-8. PMID 1511304 DOI: 10.1016/0006-8993(92)91209-W |
0.383 |
|
1990 |
Todorović S, Anderson EG. 5-HT2 and 5-HT3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons. Brain Research. 511: 71-9. PMID 2331619 DOI: 10.1016/0006-8993(90)90226-2 |
0.426 |
|
1990 |
Scroggs RS, Anderson EG. 5-HT1 receptor agonists reduce the Ca+ component of sensory neuron action potentials. European Journal of Pharmacology. 178: 229-32. PMID 2328764 DOI: 10.1016/0014-2999(90)90479-P |
0.418 |
|
1990 |
Glaum SR, Proudfit HK, Anderson EG. 5-HT3 receptors modulate spinal nociceptive reflexes. Brain Research. 510: 12-6. PMID 2322835 DOI: 10.1016/0006-8993(90)90721-M |
0.663 |
|
1989 |
Scroggs RS, Anderson EG. Serotonin modulates calcium-dependent plateau of action potentials recorded from bull frog A-type sensory neurons which is omega-conotoxin GVIA-sensitive, but dihydropyridine-insensitive. Brain Research. 485: 391-5. PMID 2470474 DOI: 10.1016/0006-8993(89)90583-0 |
0.388 |
|
1988 |
Glaum SR, Anderson EG. Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes. European Journal of Pharmacology. 156: 287-90. PMID 3240771 DOI: 10.1016/0014-2999(88)90335-4 |
0.38 |
|
1988 |
Glaum SR, Proudfit HK, Anderson EG. Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective 5-HT3 receptor antagonist. Neuroscience Letters. 95: 313-7. PMID 3226619 DOI: 10.1016/0304-3940(88)90677-5 |
0.658 |
|
1988 |
Marszalec W, Anderson EG. Three putative 5-HT1A agonists act as 5-HT antagonists in frog sensory neurons. European Journal of Pharmacology. 154: 325-8. PMID 2976672 DOI: 10.1016/0014-2999(88)90209-9 |
0.327 |
|
1988 |
Marszalec W, Scroggs RS, Anderson EG. Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites. The Journal of Pharmacology and Experimental Therapeutics. 247: 399-404. PMID 2972829 |
0.325 |
|
1986 |
Larson AA, Anderson EG. Action of hallucinogens on raphe-evoked dorsal root potentials (DRPs) in the cat. Pharmacology, Biochemistry, and Behavior. 24: 347-50. PMID 3952125 DOI: 10.1016/0091-3057(86)90364-3 |
0.4 |
|
1986 |
Holz GG, Shefner SA, Anderson EG. Serotonin decreases the duration of action potentials recorded from tetraethylammonium-treated bullfrog dorsal root ganglion cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 620-6. PMID 3485707 DOI: 10.1523/Jneurosci.06-03-00620.1986 |
0.578 |
|
1985 |
Holz GG, Shefner SA, Anderson EG. Serotonin depolarizes type A and C primary afferents: an intracellular study in bullfrog dorsal root ganglion. Brain Research. 327: 71-9. PMID 3872695 DOI: 10.1016/0006-8993(85)91500-8 |
0.619 |
|
1984 |
Holz GG, Anderson EG. The actions of serotonin on frog primary afferent terminals and cell bodies. Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology. 77: 13-21. PMID 6141866 DOI: 10.1016/0742-8413(84)90124-5 |
0.607 |
|
1983 |
Wessendorf MW, Anderson EG. Single unit studies of identified bulbospinal serotonergic units. Brain Research. 279: 93-103. PMID 6315185 DOI: 10.1016/0006-8993(83)90166-X |
0.342 |
|
1981 |
Wessendorf MW, Proudfit HK, Anderson EG. The identification of serotonergic neurons in the nucleus raphe magnus by conduction velocity. Brain Research. 214: 168-73. PMID 7237156 DOI: 10.1016/0006-8993(81)90449-2 |
0.619 |
|
1981 |
Larson AA, Chinn C, Proudfit HK, Anderson EG. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei. The Journal of Pharmacology and Experimental Therapeutics. 217: 99-104. PMID 6110778 |
0.615 |
|
1981 |
Wessendorf MW, Anderson EG, Proudfit HK. Effects of iontophoretic application of acetylcholine (Ach) and norepinephrine (NE) to identified serotonergic (5-HT) and non-serotonergic neurons in the nucleus raphe magnus (NRM) Pharmacologist. 23: No. 102. |
0.644 |
|
1980 |
Proudfit HK, Larson AA, Anderson EG. The role of GABA and serotonin in the mediation of raphe-evoked spinal cord dorsal root potentials. Brain Research. 195: 149-65. PMID 6249439 DOI: 10.1016/0006-8993(80)90873-2 |
0.644 |
|
1980 |
Goldstein BD, Hettasch JM, Anderson EG. Effects of harmaline on spinal reflex activity Pharmacologist. 22: 151. |
0.466 |
|
1976 |
Lobatz MA, Proudfit HK, Anderson EG. Effects of noxious stimulation, iontophoretic morphine and norepinephrine on neurons in nucleus raphe magnus Pharmacologist. 18: No.546. |
0.601 |
|
1975 |
Proudfit HK, Anderson EG. Morphine analgesia: blockade by raphe magnus lesions. Brain Research. 98: 612-18. PMID 1182544 DOI: 10.1016/0006-8993(75)90380-7 |
0.557 |
|
1974 |
Proudfit HK, Anderson EG. New long latency bulbospinal evoked potentials blocked by serotonin antagonists. Brain Research. 65: 542-6. PMID 4153414 DOI: 10.1016/0006-8993(74)90246-7 |
0.617 |
|
1974 |
Repkin AH, Proudfit HK, Anderson EG. Primary afferent depolarization as a mechanism of morphine analgesia Pharmacologist. 16: 074. |
0.57 |
|
1974 |
Proudfit HK, Anderson EG. Blockade of morphine analgesia by destruction of a bulbospinal serotonergic pathway Pharmacologist. 16: 073. |
0.574 |
|
1973 |
Proudfit HK, Anderson EG. Influence of serotonin antagonists on bulbospinal systems. Brain Research. 61: 331-41. PMID 4773165 DOI: 10.1016/0006-8993(73)90537-4 |
0.686 |
|
1973 |
Proudfit HK, Anderson EG. Blockade by serotonin antagonists of brain stem evoked potentials recorded fom spinal dorsal and ventral roots Federation Proceedings. 32: I. |
0.632 |
|
1972 |
Bell JA, Anderson EG. The influence of semicarbazide-induced depletion of -aminobutyric acid on presynaptic inhibition. Brain Research. 43: 161-9. PMID 4340462 DOI: 10.1016/0006-8993(72)90281-8 |
0.337 |
|
1962 |
BONNYCASTLE DD, BONNYCASTLE MF, ANDERSON EG. The effect of a number of central depressant drugs upon brain 5-hydroxytryptamine levels in the rat. The Journal of Pharmacology and Experimental Therapeutics. 135: 17-20. PMID 13871074 |
0.625 |
|
1962 |
ANDERSON EG, MARKOWITZ SD, BONNYCASTLE DD. Brain 5-hydroxytryptamine and anticonvulsant activity. The Journal of Pharmacology and Experimental Therapeutics. 136: 179-82. PMID 13861220 |
0.615 |
|
1960 |
ANDERSON EG, BONNYCASTLE DD. A study of the central depressant action of pentobarbital, phenobarbital and diethyl ether in relationship to increases in brain 5-hy-droxytryptamine. The Journal of Pharmacology and Experimental Therapeutics. 130: 138-43. PMID 13683196 |
0.625 |
|
1956 |
ANDERSON EG, MAGEE DF. A study of the mechanism of the effect of dietary fat in decreasing thiopental sleeping time. The Journal of Pharmacology and Experimental Therapeutics. 117: 281-6. PMID 13332574 |
0.446 |
|
1955 |
MAGEE DF, ANDERSON EG. Changes in pancreatic enzymes brought about by alteration in the nature of the dietary protein. The American Journal of Physiology. 181: 79-82. PMID 14376575 |
0.428 |
|
1953 |
ANDERSON EG, MAGEE DF. Effect of feeding fat on duration of thiopental anesthesia. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 83: 110-1. PMID 13064191 |
0.467 |
|
Show low-probability matches. |